Connective tissue growth factor: an attractive therapeutic target in fibrotic renal disease

Bibliography

• BORDER WA, NOBLE NA: Transforming growth factor beta in tissue fibrosis. N Engl. Med. (1994) 331(19):1286–1292.
   PubMed Web of Science ®Google Scholar
• BRIGSTOCK DR. The connective tissue growth factoricysteine-rich 61/ nephroblastoma overexpressed (CCN) family. Endocr. Rev. (1999) 20(2):189–206.
   PubMed Web of Science ®Google Scholar
• GROTENDORST GR, LAU LF, PERBAL B: CCN proteins are distinct from and should not be considered members of the insulin-like growth factor-binding protein superfamily. Endocrinology (2000) 141(6):2254–2256.
   PubMed Web of Science ®Google Scholar
• GUPTA S, CLARKSON MR, DUGGAN J, BRADY HR: Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int. (2000) 58:1389–1399.
   PubMed Web of Science ®Google Scholar
• RYSECK RP, MACDONALD-BRAVO H, MATTEI MG, BRAVO R: Structure, mapping and expression of fisp-12, a growth factor inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ. (1991) 2:225–233.
   PubMedGoogle Scholar
• ITO Y, BENDE RJ, OEMER BS, RABELINK TJ, WEENING JJ, GOLDSCHMEDING R: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. (1998) 53:853–861.
   PubMed Web of Science ®Google Scholar
• ••First study of the expression of CTGF inthe diseased kidney.
   Google Scholar
• GOUMENOS DS, TSAMANDAS AC, OLDROYD S et al.: Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease. Nephron (2001) 3:240–248
   Google Scholar
• MURPHY M, GODSON C, CANNON S et al.: Suppression subtractive hybridisation identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. Biol. Chem (1999) 274(9):5830–5834.
   Web of Science ®Google Scholar
• ••First demonstration that CTGF isupregulated in models of diabetic nephropathy.
   Google Scholar
• FLOEGE J, FEEHALLY J: IgA nephropathy: recent developments. j Am. Soc. Nephrol (2000) 11(12):2395–2403.
   PubMed Web of Science ®Google Scholar
• RISER BL, VARANI J, CORTES P, YEE J, DAME M, SHARBA AK: Cyclic stretching of mesangial cells up-regulates intercellular adhesion molecule-1 and leukocyte adherence: a possible new mechanism for glomerulosclerosis. Am. I Pathol (2001) 158(1):11–17.
   PubMed Web of Science ®Google Scholar
• EDDY AA: Molecular basis of renal fibrosis. Pediatr Nephrol (2001) 5(3-4):290–301.
   Google Scholar
• MORIYAMA T, KAWADA N, NAGATOYA K, HORIO M, IMAI E, HORI M: Oxidative stress in tubulointerstitial injury: therapeutic potential of antioxidants towards interstitial fibrosis. Nephrol Dial. Transplant. (2000) 1.5(S6):47–49.
   Google Scholar
• KRIZ W: Progressive renal failure - inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial. Transplant. (1996) 11(9):1738–1742.
   PubMed Web of Science ®Google Scholar
• GILBERT RE, COOPER ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int. (1999) 56(5):1627–1637.
   Google Scholar
• SHARMA K, ZIYADEH FN: Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-beta as a key mediator. Diabetes (1995) 44(10):1139–1146.
   PubMed Web of Science ®Google Scholar
• EDDY AA: Molecular insights into renal interstitial fibrosis. I Am. Soc. Nephrol (1996) 7(12):2495–2508.
   PubMed Web of Science ®Google Scholar
• BLOBE GC, SCHIEMANN WP, LODISH HF: Role of transforming growth factor beta in human disease. N Engl. j Med. (2000) 342(18):1350–1358.
   PubMed Web of Science ®Google Scholar
• BARICOS WH, CORTEZ SL, DEBOISBLANC M, XIN S: Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. I Am. Soc. Nephrol (1999) 10(4):790–795.
   PubMed Web of Science ®Google Scholar
• ZIYADEH FN. The extracellular matrix in diabetic nephropathy. Am. j Kidney Dis. (1993) 22(5):736–744.
   PubMed Web of Science ®Google Scholar
• HUMES HD, NAKAMURA T, CIESLINSKI DA, MILLER D, EMMONS RV, BORDER WA: Role of proteoglycans and cytoskeleton in the effects of TGF-beta 1 on renal proximal tubule cells. Kidney Int. (1993) 43(3):575–584.
   PubMed Web of Science ®Google Scholar
• NAKAMURA T, MILLER D, RUOSLAHTI E, BORDER WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int. (1992) 41(5):1213–1221.
   PubMed Web of Science ®Google Scholar
• ZIYADEH FN, HAN DC: Involvement of transforming growth factor-beta and its receptors in the pathogenesis of diabetic nephrology. Kidney Int (1997) 60:S7–11.
   Google Scholar
• •Key paper establishing the role of TGF-in diabetes.
   Google Scholar
• LAIHO M, SAKSELA O, KESKI-OJA J: Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts. Exp Cell Res. (1986) 164(2):399–407.
   PubMed Web of Science ®Google Scholar
• WOLF G: Cell cycle regulation in diabetic nephropathy. Kidney Int. (2000) 58(S77):59–66.
   Google Scholar
• RODEMANN HP, BINDER A, BURGER A, GUVEN N, LOFFLER H, BAMBERG M: The underlying cellular mechanism of fibrosis. Kidney mt. Suppl. (1996) 54:32–36.
   Google Scholar
• STRUTZ F, OKADA H, LO CW et al.: Identification and characterization of a fibroblast marker: FSP1. _J. Cell Biol. (1995) 130(2):393–405.
   PubMed Web of Science ®Google Scholar
• OKADA H, DANOFF TM, KALLURI R, NEILSON EG. Early role of Fspl in epithelial-mesenchymal transformation. Am. J Physiol.(1997) 273(4 Pt 2):F563–574.
   Google Scholar
• BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (1990) 346(6282):371–374.
   PubMed Web of Science ®Google Scholar
• ••A key paper demonstrating that targetingTGF- p could be a therapeutic strategy.
   Google Scholar
• LETTERIO JJ, ROBERTS AB: Regulation of immune responses by TGF beta. Ann. Rev. Immuriol.. (1998) 16:137–161.
   PubMed Web of Science ®Google Scholar
• SHULL MM, ORMSBY I, KIER AB et al.: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (1992) 359(6397):693–699.
   PubMed Web of Science ®Google Scholar
• ALMENDRAL JM, SOMMER D, MACDONALD-BRAVO H, BURCKHARDT J, PERERA J, BRAVO R: Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol. Cell Biol. (1988) 8(5):2140–2148.
   PubMedGoogle Scholar
• RYSECK RP, MACDONALD-BRAVO H, MATTEI MG, BRAVO R: Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth DIME (1991) 2(5):225–233.
   PubMedGoogle Scholar
• BRADHAM DM, IGARASHI A, POTTER RL, GROTENDORST GR: Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. _J. Cell Biol. (1991) 114(6):1285–1294.
   PubMed Web of Science ®Google Scholar
• •First isolation of human CTGE
   Google Scholar
• HARDING PA, SURVEYOR GA, BRIGSTOCK, DR: Characterization of pig connective tissue growth factor (CTGF) cDNA, mRNA and protein from uterine tissue. DNA Seq. (1998) 8(6):385–390.
   PubMed Web of Science ®Google Scholar
• YING Z, KING ML: Isolation and characterization of xnov, a Xeriopus laevis orthologue of the chicken nov gene. Cerie (1998) 171(2):243–248.
   Google Scholar
• XU J, SMOCK SL, SAFADI FF et al.: Cloning the full-length cDNA for rat connective tissue growth factor: implications for skelet al development. Cell. Biochem. (2000) 77(1):103–115.
   PubMed Web of Science ®Google Scholar
• LIN J, LILIENSIEK B, KANITZ M et al.: Molecular cloning of genes differentially regulated by TNF-alpha in bovine aortic endothelial cells, fibroblasts and smooth muscle cells. Cardiovasc. Res. (1998) 38(3):802–813.
   PubMed Web of Science ®Google Scholar
• FRAZIER K, WILLIAMS S, KOTHAPALLI D, KLAPPER H, GROTENDORST GR: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. j Invest. Dermatol. (1996) 107(3):404–411.
   PubMed Web of Science ®Google Scholar
• BORK P: the modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Letters (1993) 327:125–130.
   PubMed Web of Science ®Google Scholar
• KIM HS, NAGALLA SR, OH Y, WILSON E, ROBERTS CT JR ROSENFELD RG: Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc. Nati Acad. St". USA (1997) 94(24):12981–12986.
   Google Scholar
• BURREN CP, WILSON EM, HWA V, OH Y, ROSENFELD RG: Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP superfamily. j Clin. Eridocrinol. Metab. (1999) 84(3):1096–1103.
   PubMed Web of Science ®Google Scholar
• HWA V, OH Y, ROSENFELD RG: The insulin-like growth factor-binding protein (IGFBP) superfamily. Eridocr. Rev (1999) 20(6):761–787.
   PubMed Web of Science ®Google Scholar
• MARTINERIE C, VIEGAS-PEQUIGNOT E, GUENARD I et al.: Physical mapping of human loci homologous to the chicken nov proto-oncogene. Oricogerie (1992) 7(12):2529–2534.
   Google Scholar
• DE GROOT RP, KRUIJER W: Transcriptional activation by TGF beta 1 mediated by the dyad symmetry element (DSE) and the TPA responsive element (TRE). Biochem. Biophys. Res. Commun. (1990) 168(3):1074–1081.
   PubMed Web of Science ®Google Scholar
• GROTENDORST GR, OKOCHI H, HAYASHI N: A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell. Growth Differ (1996) 7(4):469–480.
   PubMedGoogle Scholar
• ••Important paper establishing that CTGFexpression is at least partly under the control of a TGF- p response element in the CTGF promoter.
   Google Scholar
• BLOM IE, VAN DIJK AJ, DE WEGER RA, TILANUS MG, GOLDSCHMEDING R: Identification of human Ccri2 (connective tissue growth factor) promoter polymorphisms. Mol. Pathol. (2001) 54(3):192–196.
   PubMedGoogle Scholar
• KUBOTA S, HATTON T, NAKANISHI T, TAGIWAWA M: Involvement of cis-acting repressive element(s) in the 3'-untranslated region of human connective tissue growth factor gene. FEBS Lett. (1999) 450 (1-2):84–88.
   PubMed Web of Science ®Google Scholar
• HURLE B, SEGADE F, RODRIGUEZ R, RAMOS S, LAZO PS: The mouse tumor necrosis factor receptor 2 gene: genomic structure and characterization of the two transcripts. Ceriomics (1998) 52(1):79–89.
   Google Scholar
• STANHOPE-BAKER P, WILLIAMS BR: Identification of connective tissue growth factor as a target of WT1 transcriptional regulation. j Biol. Chem. (2000) 275(49) :38139–38150.
   PubMed Web of Science ®Google Scholar
• DAMMEIER J, BEER, H, BRAUCHLE M, WERNER S: Dexamethasone is a potent inducer of connective tissue growth factor expression. J. Biol. Chem. (1998) 273(29):18115–18190.
   Web of Science ®Google Scholar
• RICUPERO DA, ROMERO JR, RISHIKOF DC, GOLDSTEIN RH: Des-Arg(10)-kallidin engagement of the B1 receptor stimulates Type I collagen synthesis via stabilization of connective tissue growth factor mRNA. J. Biol. Chem. (2000) 275(17):12475–12480.
   PubMed Web of Science ®Google Scholar
• PENDURTHI UR, ALLEN KE, EZBAN M, RAO LV: Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in Factor VIIa x tissue factor-induced signal transduction. J. Biol. Chem. (2000) 275(19):14632–14641.
   PubMed Web of Science ®Google Scholar
• CHAMBERS RC, LEONI P, BLANC-BRUDE OP, WEMBRIDGE DE, LAURENT GJ: Thrombin is a potent inducer of connective tissue growth factor through proteolytic activation of protease activated receptor 1. _J. Biol. Chem. (2000) 275(45):35584–35591.
   PubMed Web of Science ®Google Scholar
• ABRAHAM DJ, SHIWEN X, BLACK CM, SA S, XU Y, LEASK A: Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J. Biol. Chem. (2000) 275(20):15220–15225.
   PubMed Web of Science ®Google Scholar
• BOES M, DAKE BL, BOOTH BA et al.: Connective tissue growth factor (IGFBP-rP2) expression and regulation in cultured bovine endothelial cells. Endocrinology (1999) 140(4):1575–1580.
   PubMed Web of Science ®Google Scholar
• SUZUMA K, NARUSE K, SUZUMA I et al.: Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Fltl, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J. Biol. Chem. (2000) 275(52):40725–40731.
   PubMed Web of Science ®Google Scholar
• IGARASHI A, OKOCHI H, BRADHAM DM, GROTENDORST GR: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol. Biol. Cell (1993) 4(6):637–645.
   PubMed Web of Science ®Google Scholar
• BRIGSTOCK DR, STEFFEN CL, KIM GY, VEGUNTA RK, DIEHL JR, HARDING PA: Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J. Biol. Chem. (1997) 272(32):20275–20282.
   Google Scholar
• HISHIKAWA K, NAKAKI T, FUJII T: Transforming growth factor-beta(1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells. Eur. j Pharmacol (1999) 385(2-3):287–290.
   PubMed Web of Science ®Google Scholar
• HISHIKAWA K, OEMAR BS, TANNER FC, NAKAKI T, LUSCHER TF, FUJII T: Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. _J. Biol. Chem. (1999) 274(52):37461–37466.
   PubMed Web of Science ®Google Scholar
• SHIMO T, NAKANISHI T, KIMURA Y et al.: Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J. Biochem. (Tokyo) (1998) 124(1):130–140.
   PubMed Web of Science ®Google Scholar
• SHIMO T, NAKANISHI T, NISHIDA T: Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in viva I Biochem. (Tokyo) (1999) 126(1):137–145.
   Google Scholar
• KUBOTA S, HATTORI T, SHIMO T, NAKANISHI T, TAKIGAWA M: Novel intracellular effects of human connective tissue growth factor expressed in Cos-7 cells. FEBS Letters (2000) 474(1):58–62.
   PubMed Web of Science ®Google Scholar
• KOTHAPALLI D, FRAZIER KS, WELPLY A, SEGARINI PR, GROTENDORST GR: Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell. Growth Differ (1997) 8(1):61–68.
   PubMedGoogle Scholar
• KOTHAPALLI D, HAYASHI N, GROTENDORST GR: Inhibition of TGF-beta-stimulated CTGF gene expression and anchorage-independent growth by cAMP identifies a CTGF-dependent restriction point in the cell cycle. FASEB J. (1998) 12(12):1151–1161.
   PubMed Web of Science ®Google Scholar
• BLOM I, VAN DIJK AJ, WIETEN L et al.: In vitro evidence for differential involvement of CTGF, TGF-6, and PDGF-BB in mesangial response to injury. Nephrol Dial. Transplant. (2001) 16(6):1139–1148.
   PubMed Web of Science ®Google Scholar
• KIREEVA ML, LATINKIC BV, KOLESNIKOVA TV et al.: Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp. Cell Res. (1997) 233(1):63–77.
   PubMed Web of Science ®Google Scholar
• NISHIDA T, NAKANISHI T, ASANO M, SHIMO T, TAKIGAWA M: Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J. Cell Physiol (2000) 184(2):197–206.
   PubMed Web of Science ®Google Scholar
• BABIC AM, CHEN CC, LAU LF: Fisp12/ mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol. Cell. Biol. (1999) 19(4):2958–2966.
   PubMed Web of Science ®Google Scholar
• LAU LF, LAM SC: The CCN family of angiogenic regulators: the integrin connection. Exp. Cell Res. (1999) 248(1):44–57.
   PubMed Web of Science ®Google Scholar
• •A nice review of the role of integrins as receptors for the CCN family.
   Google Scholar
• CHEN CC, CHEN N, LAU L: The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J. Biol. Chem. (2001) 276(13):10443–10452.
   PubMed Web of Science ®Google Scholar
• CHEN MM, LAM A, ABRAHAM JA, SCHREINER GF, JOLY AH: CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. j. Mol. Cell. Cardin]. (2000) 32(10):1805–1819.
   PubMed Web of Science ®Google Scholar
• SCHWAB JM, POSTLER E, NGUYEN TD, MITTELBRONN M, MEYERMANN R, SCHLUESENER HJ: Connective tissue growth factor is expressed by a subset of reactive astrocytes in human cerebral infarction. Neuropathol. Appl. Neurobiol. (2000) 26(5):434–440.
   PubMed Web of Science ®Google Scholar
• PARADIS V, DARGERE D, VIDAUD M et al.: Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology (1999) 30(4):968–976.
   PubMed Web of Science ®Google Scholar
• LASKY JA, ORTIZ LA, TONTHAT B et al.: Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am. J. Physic] (1998) 275(2 Pt 1):365–371.
   Google Scholar
• SURVEYOR GA, BRIGSTOCK DR: Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days 7 and 14 of gestation. Growth Factors (1995) 17(2):115–124.
   Google Scholar
• TAMATANI T, KOBAYASHI H, TEZUKA K et al: Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of binary atresia. Biochem. Biophys. Res. Commun. (1998) 251(3):748–752.
   PubMed Web of Science ®Google Scholar
• YANG DH, KIM HS, WILSON EM, ROSENFELD RG, OH Y: Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. j Chu. Eridocnitol Met all. (1998) 83(7):2593–2596.
   Google Scholar
• WANDJI SA, GADSBY JE, BARBER JA, HAMMOND JM: Messenger ribonucleic acids for MAC25 and connective tissue growth factor (CTGF) are inversely regulated during folliculogenesis and early luteogenesis. Endocrinology (2000) 141(7):2648–2657.
   PubMed Web of Science ®Google Scholar
• IGARASHI A, NASHIRO K, KIKUCHI K et al.: Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. j Invest. Dermatol (1995) 105(2):280–284.
   PubMed Web of Science ®Google Scholar
• •Paper establishing CTGF as a marker in fibrotic skin disease and identifying it as a putative therapeutic target.
   Google Scholar
• IGARASHI A, NASHIRO K, KIKUCHI K et al.: Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. j Invest. Dermatol (1996) 106(4):729–733.
   PubMed Web of Science ®Google Scholar
• OEMAR BS, WERNER A, GARNIER JM et al.: Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation (1997) 95(4):831–839.
   PubMed Web of Science ®Google Scholar
• DAMMEIER J, BRAUCHLE M, FALK W, GROTENDORST GR, WERNER S: Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int. Biochem. Cell Biol. (1998) 30(8):909–922.
   Google Scholar
• QUERFELD C, SOLLBERG S, HUERKAMP C, ECKES B, KRIEG T: Pseudoscleroderma associated with lung cancer: correlation of collagen Type I and connective tissue growth factor gene expression. Br. I Dermatol (2000) 142(6):1228–1233.
   PubMed Web of Science ®Google Scholar
• WENGER C, ELLENRIEDER V, ALBER B et al.: Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oricogerie (1999) 18(4):1073–1080.
   Google Scholar
• DI MOLA FF, FRIESS H, MARTIGNONI ME et al: Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann. Surg. (1999) 230(1):63–71.
   PubMed Web of Science ®Google Scholar
• WILLIAMS EJ, GACA MD, BRIGSTOCK DR, ARTHUR MJ, BENYON RC: Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. j Hepatol. (2000) 32(5):754–761.
   PubMed Web of Science ®Google Scholar
• ITO Y, GOLDS CHMEDING R, BENDE R et al: Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. I Am. Soc. Nephrol (2001) 12(3):472–84.
   PubMed Web of Science ®Google Scholar
• ••Another excellent paper looking at thekinetics of CTGF expression in an animal model of glomerulonephritis.
   Google Scholar
• FRAZIER KS, PAREDES A, DUBE P, STYER E: Connective tissue growth factor expression in the rat remnant kidney model and association with tubular epithelial cells undergoing transdifferentiation. Vet. Pathol (2000) 37(4):328–335.
   PubMed Web of Science ®Google Scholar
• RISER BL, DENICHILO M, CORTES P et al.: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. Am. Soc. Nephrol. (2000) 11(1):25–38.
   PubMed Web of Science ®Google Scholar
• HISHIKAWA K, OEMAR BS, NAKAKI T: Static pressure regulates connective tissue growth factor expression in human mesangial cells. I Biol. Chem. (2001) fepub ahead of print I.
   Google Scholar
• HAHN A, HEUSINGER-RIBEIRO J, LANZ T, ZENKEL S, GOPPELT-STREUBE M: Induction of connective tissue growth factor by activation of heptahelical receptors; modulation by Rho proteins and the actin cytoskeleton. _J. Biol. Chem. (2000) 275(48):37429–37435.
   PubMed Web of Science ®Google Scholar
• SHAKUNAGA T, OZAKI T, OHARA N et al.: Expression of connective tissue growth factor in cartilaginous tumors. Cancer (2000) 89(7):1466–1473.
   PubMed Web of Science ®Google Scholar
• DUNCAN MR, FRAZIER KS, ABRAMSON S et al.: Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEBI (1999) 13(13):1774–1786.
   PubMed Web of Science ®Google Scholar
• NAKANISHI T, NISHIDA T, SHIMO T et al: Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology (2000) 141(1):264–273.
   PubMed Web of Science ®Google Scholar